CRISPR/Cas9-mediated sequential or simultaneous knockout of multiple genes in Saccharomyces cerevisiae for functional genomics and metabolic engineering.
Efficient CRISPR/Cas9 system tailored for multi-gene knockout in S. cerevisiae, with scalable workflow and full sequence verification.
We combine custom guide RNA design, high-efficiency transformation, and a marker-recycling strategy to disrupt multiple genomic loci in Saccharomyces cerevisiae sequentially or in parallel. This workflow is tailored for projects requiring 2–10+ gene knockouts in a single strain, enabling systematic functional analysis and metabolic reprogramming.
Custom gRNAs designed against user-specified target sequences, including multiple isoform considerations.
High-efficiency transformation of S. cerevisiae with CRISPR plasmids; colonies screened on selective media.
Colony PCR spanning each deletion junction followed by Sanger sequencing to confirm complete knockout.
All deliverables are scoped at project start and provided with project documentation.
Our service is tailored to your specific targets. The table below outlines typical scoping parameters; all details are finalized during consultation.
| Parameter | Typical project scope |
|---|---|
| Host Strain | Saccharomyces cerevisiae (lab strains; customer-provided strain considered case-by-case) |
| Number of Target Genes | 2 to 10+ genes per project; sequential or simultaneous editing strategy defined at design |
| gRNA Design | Custom design using validated algorithms; on-target scoring and off-target prediction provided |
| Transformation Method | Lithium acetate/PEG high-efficiency protocol; alternative methods considered on request |
| Selectable Markers | Auxotrophic (e.g., URA3, LEU2) or antibiotic (e.g., G418, hygromycin) as scoped; marker recycling available for multi-round editing |
| Validation | Colony PCR for each deletion junction; Sanger sequencing of PCR amplicons. Off-target analysis by in silico prediction + optional targeted amplicon sequencing |
From target selection to validated strain — a structured 5-step process.
You provide gene names or sequences; our bioinformatics team designs optimized guide RNAs for each target, including off-target scoring. Designs are reviewed with you before proceeding.
Each gRNA is cloned into a Cas9 expression vector. Plasmids are sequence-verified and prepared in sufficient quantity for transformation.
Competent yeast cells are transformed with the CRISPR plasmid using a lithium acetate/PEG protocol. Transformed cells are plated on selective medium and incubated until colonies appear.
For multi-round editing, the marker is excised from the genome (e.g., by flanking loxP sites or homologous recombination), enabling its reuse in the next deletion round.
Individual colonies are picked, genomic DNA is extracted, and each target locus is amplified by PCR. Sanger sequencing confirms the intended knockout; verified clones are cryopreserved.
Investigate gene function and genetic interactions by systematically deleting multiple genes. Identify synthetic lethal pairs or pathway redundancy.
Disrupt specific metabolic routes or regulatory elements to study impacts on carbon flux and product formation in yeast.
Construct minimal genomes or engineer strains with designer modules by removing non-essential genes while retaining robust growth.
Common questions about our multi-gene knockout service.
Project duration depends on the number of targets, sequence complexity, and whether screening is done sequentially or in parallel. A typical 3–5 gene knockout project may require a timeline confirmed during project scoping, including design, transformation rounds, and validation. An exact timeline is determined during consultation and depends on target biology and available resources.
We routinely perform knockouts of 2–10 genes. For larger sets, we recommend a sequential strategy with marker recycling. Projects with more than 10 targets can be scoped on a case-by-case basis, and we work with you to investigate most efficient editing order and selection scheme.
Each deletion is verified by colony PCR across the target locus and Sanger sequencing of the PCR product. We also provide in silico off-target prediction for each gRNA. Optional targeted amplicon sequencing for predicted off-target sites can be included in the scope. All QC data is supplied with the final strain.
Yes, we can accept customer-provided S. cerevisiae strains, provided they are amenable to our transformation protocol (competent cell preparation). Strain background and any pre-existing markers are evaluated during the design phase to support compatibility with the multi-gene editing workflow.
Get a customized quote for your Yeast Multi-Gene Knockout Strain Construction project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.